10 Participants Needed

Antioxidant Serum + Laser Treatment for Acne

AS
CK
Overseen ByCeleste Katona, BA
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

You might need to stop certain medications if they could interfere with the study. This includes high doses of anti-inflammatory drugs and immunosuppressive drugs. Also, if you're using certain skin treatments or prescription medications on your face, you may need to stop those before joining the trial.

What data supports the effectiveness of the Antioxidant Serum + Laser Treatment for Acne?

Research shows that antioxidant serums containing vitamins C and E, along with ferulic acid, can protect skin from sun damage and improve skin health. These ingredients help stabilize each other and enhance skin protection, which may also benefit acne treatment by reducing inflammation and promoting skin repair.12345

Is the combination of antioxidant serum and laser treatment safe for human use?

Research shows that the combination of Vitamin C, E, and Ferulic acid serum, when used with laser treatments, generally has a good safety profile and can improve skin healing. However, there may be some unintended side effects when these serums are used in ways not originally intended, such as through laser-assisted delivery.23567

How is the Antioxidant Serum + Laser Treatment for Acne different from other acne treatments?

This treatment is unique because it combines a topical antioxidant serum containing vitamins C and E with ferulic acid, which enhances the stability and effectiveness of the vitamins, providing increased protection against skin damage from sunlight. This approach not only targets acne but also offers additional benefits like reducing skin aging and damage from UV exposure, which is not typically addressed by standard acne treatments.12378

What is the purpose of this trial?

This is a split-face, single-blind study assessing the use of an antioxidant serum with a series of acne laser treatments to reduce sebum production in healthy male and female subjects between the ages of 18 and 65 years, inclusive, with Fitzpatrick skin types I-VI.

Research Team

Edward (Ted) Lain, M.D. - AICR

Edward L Lain, MD

Principal Investigator

Austin Institute for Clinical Research

Eligibility Criteria

This trial is for healthy men and women aged 18-65 with mild to moderate acne who perceive their skin as oily. Participants must use approved birth control, have no health issues affecting the study, and agree to follow the study's rules including signing consent forms.

Inclusion Criteria

My acne is mild to moderate.
I am between 18 and 65 years old and have a skin type ranging from very fair to very dark.
No known medical conditions that, in the Investigator's opinion may interfere with study participation
See 4 more

Exclusion Criteria

My skin is clear of sunburn, tattoos, scars, or other marks that could affect test results.
Subjects participating in other facial clinical studies
I have not had non-ablative laser or IPL treatments in the last 3 months.
See 9 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a topical antioxidant serum and undergo laser treatments to reduce sebum production

10 weeks
Visits on Day 0, 14, 42, and 70

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks
Final follow-up visit on Day 98

Treatment Details

Interventions

  • Topical Antioxidant Serum
Trial Overview The study tests if a topical antioxidant serum can boost the effectiveness of AviClear laser treatments in reducing sebum production on one side of the face compared to laser treatment alone on the other side.
Participant Groups
2Treatment groups
Active Control
Group I: Topical Antioxidant Serum containing Silymarin CF (Right Face)Active Control2 Interventions
14 day application of topical antioxidant serum containing Silymarin CF Subjects will be given study drug and instructed to topically apply to the treatment area, the respectively randomized half of the face, once daily for 14 consecutive days.
Group II: Topical Antioxidant Serum containing Silymarin CF (Left Face)Active Control2 Interventions
14 day application of topical antioxidant serum containing Silymarin CF Subjects will be given study drug and instructed to topically apply to the treatment area, the respectively randomized half of the face, once daily for 14 consecutive days.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Austin Institute for Clinical Research

Lead Sponsor

Trials
6
Recruited
140+

SkinCeuticals

Collaborator

Trials
4
Recruited
110+

Findings from Research

The enhanced vitamin C serum (eVCS) significantly increased collagen levels in treated skin explants by 145% compared to control, indicating its potential to improve skin structure.
The combination of eVCS with a retinol-bakuchiol serum (RSB) was more effective in reducing pigmentation than eVCS alone, showing significant clinical improvement in facial hyperpigmentation and photodamage over a 12-week study with 29 female participants.
Antioxidant Skincare Treatment for Hyperpigmented and Photodamaged Skin: Multi-Center, Open-Label, Cross-Seasonal Case Study.Hooper, D., Tedaldi, R., Iglesia, S., et al.[2023]
In a study involving 12 healthy female participants, a topical antioxidant complex with vitamins C and E and ferulic acid significantly protected against skin damage caused by solar-simulated ultraviolet irradiation (ssUVR).
The antioxidant complex reduced harmful effects such as sunburn cell formation and thymine dimer formation, indicating its potential as an effective photoprotective treatment for acute skin damage.
Protective effects of a topical antioxidant complex containing vitamins C and E and ferulic acid against ultraviolet irradiation-induced photodamage in Chinese women.Wu, Y., Zheng, X., Xu, XG., et al.[2013]
Incorporating ferulic acid into a topical solution with 15% l-ascorbic acid and 1% alpha-tocopherol significantly enhances the stability of these vitamins and doubles the skin's protection against UV damage, increasing photoprotection from 4-fold to approximately 8-fold.
The antioxidant formulation not only reduces skin cell damage by inhibiting apoptosis (cell death) through lower levels of caspase-3 and caspase-7 but also effectively decreases thymine dimer formation, suggesting it could be beneficial in preventing photoaging and skin cancer.
Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin.Lin, FH., Lin, JY., Gupta, RD., et al.[2013]

References

Antioxidant Skincare Treatment for Hyperpigmented and Photodamaged Skin: Multi-Center, Open-Label, Cross-Seasonal Case Study. [2023]
Protective effects of a topical antioxidant complex containing vitamins C and E and ferulic acid against ultraviolet irradiation-induced photodamage in Chinese women. [2013]
Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. [2013]
A Double-Blind, Comparative Clinical Study of Newly Formulated Retinol Serums vs Tretinoin Cream in Escalating Doses: A Method for Rapid Retinization With Minimized Irritation. [2021]
Ferulic acid photoprotective properties in association with UV filters: multifunctional sunscreen with improved SPF and UVA-PF. [2018]
Safety profile of laser-assisted drug delivery of vitamin C, E, and ferulic acid serum following ablative fractional resurfacing: A retrospective chart review. [2022]
7.United Arab Emiratespubmed.ncbi.nlm.nih.gov
Ferulic Acid Activity in Topical Formulations: Technological and Scientific Prospecting. [2021]
Antioxidants in dermocosmetology: from the laboratory to clinical application. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security